Fig. 3From: Assessment of hepatocellular carcinoma treatment response with LI-RADS: a pictorial reviewHepatocellular carcinoma (HCC) treatment options divided by modality. Locoablative therapies (PEA, RFA, MWA), transcatheter therapies (TAE, TACE, DEB-TACE, TARE) and radiation therapies (SBRT) are the most commonly used locoregional treatments for HCC treatment and are reviewed in this articleBack to article page